More than 40 gynecology experts sent an open letter to FDA suggesting the agency went too far in its November 2014 warning against the use of power morcellators during surgery to treat uterine fibroids. The agency issued the "black box" warning
to prevent the possible spread of uterine sarcomas, or cancers, and to decrease the long-term survival of patients.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?